Literature DB >> 23891909

Connexin 43 deficiency desensitizes bone to the effects of mechanical unloading through modulation of both arms of bone remodeling.

Shane A Lloyd1, Alayna E Loiselle, Yue Zhang, Henry J Donahue.   

Abstract

Connexin 43 (Cx43) is a gap junction protein that plays an integral role in the skeletal response to mechanical loading and unloading. In a previous study, we demonstrated preservation of trabecular bone mass and cortical bone formation rate in mice with an osteoblast/osteocyte-selective deficiency of Cx43 (cKO) following mechanical unloading via hindlimb suspension (HLS). In the present study, we sought to define the potential mechanisms underlying this response. Following three weeks of HLS, mRNA levels of Sost were significantly greater in wild-type (WT)-Suspended mice vs. WT-Control, while there was no difference between cKO control and cKO-Suspended. Unloading-induced decreases in P1NP, a serum marker of bone formation, were also attenuated in cKO-Suspended. The proportion of sclerostin-positive osteocytes was significantly lower in cKO-Control vs. WT-Control (-72%, p<0.05), a difference accounted for by the presence of numerous empty lacunae in the cortical bone of cKO vs. WT. Abundant TUNEL staining was present throughout the cortical bone of the tibia and femur, suggesting an apoptotic process. There was no difference in empty lacunae in the trabecular bone of the tibia or femur. Trabecular and cortical osteoclast indices were lower in cKO-Suspended vs. WT-Suspended; however, mRNA levels of the gene encoding RANKL increased similarly in both genotypes. Connexin 43 deficient mice experience attenuated sclerostin-mediated suppression of cortical bone formation and lower cortical osteoclast activity during unloading. Preservation of trabecular bone mass and attenuated osteoclast activity during unloading, despite an apparent lack of effect on osteocyte viability at this site, suggests that an additional mechanism independent of osteocyte apoptosis may also be important. These findings indicate that Cx43 is able to modulate both arms of bone remodeling during unloading.
© 2013. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Connexin 43; Osteocyte apoptosis; RANKL; Sclerostin; Unloading

Mesh:

Substances:

Year:  2013        PMID: 23891909      PMCID: PMC4480865          DOI: 10.1016/j.bone.2013.07.022

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  40 in total

1.  Connexin43 interacts with βarrestin: a pre-requisite for osteoblast survival induced by parathyroid hormone.

Authors:  Nicoletta Bivi; Virginia Lezcano; Milena Romanello; Teresita Bellido; Lilian I Plotkin
Journal:  J Cell Biochem       Date:  2011-10       Impact factor: 4.429

2.  Wnt-1 regulation of connexin43 in cardiac myocytes.

Authors:  Z Ai; A Fischer; D C Spray; A M Brown; G I Fishman
Journal:  J Clin Invest       Date:  2000-01       Impact factor: 14.808

3.  Connexin 43 deficiency attenuates loss of trabecular bone and prevents suppression of cortical bone formation during unloading.

Authors:  Shane A Lloyd; Gregory S Lewis; Yue Zhang; Emmanuel M Paul; Henry J Donahue
Journal:  J Bone Miner Res       Date:  2012-11       Impact factor: 6.741

4.  Osteocyte apoptosis is induced by weightlessness in mice and precedes osteoclast recruitment and bone loss.

Authors:  J Ignacio Aguirre; Lilian I Plotkin; Scott A Stewart; Robert S Weinstein; A Michael Parfitt; Stavros C Manolagas; Teresita Bellido
Journal:  J Bone Miner Res       Date:  2006-04-05       Impact factor: 6.741

5.  Cell autonomous requirement of connexin 43 for osteocyte survival: consequences for endocortical resorption and periosteal bone formation.

Authors:  Nicoletta Bivi; Keith W Condon; Matthew R Allen; Nathan Farlow; Giovanni Passeri; Lucas R Brun; Yumie Rhee; Teresita Bellido; Lilian I Plotkin
Journal:  J Bone Miner Res       Date:  2012-02       Impact factor: 6.741

6.  Development of mice with osteoblast-specific connexin43 gene deletion.

Authors:  Charles H M Castro; Joseph P Stains; Sharmin Sheikh; Vera Lucia Szejnfeld; Klaus Willecke; Martin Theis; Roberto Civitelli
Journal:  Cell Commun Adhes       Date:  2003 Jul-Dec

7.  Cardiac malformation in neonatal mice lacking connexin43.

Authors:  A G Reaume; P A de Sousa; S Kulkarni; B L Langille; D Zhu; T C Davies; S C Juneja; G M Kidder; J Rossant
Journal:  Science       Date:  1995-03-24       Impact factor: 47.728

8.  Mechanobiology of the skeleton.

Authors:  Charles H Turner; Stuart J Warden; Teresita Bellido; Lilian I Plotkin; Natarajan Kumar; Iwona Jasiuk; Jon Danzig; Alexander G Robling
Journal:  Sci Signal       Date:  2009-04-28       Impact factor: 8.192

9.  Sclerostin antibody inhibits skeletal deterioration due to reduced mechanical loading.

Authors:  Jordan M Spatz; Rachel Ellman; Alison M Cloutier; Leeann Louis; Miranda van Vliet; Larry J Suva; Denise Dwyer; Marina Stolina; Hua Zhu Ke; Mary L Bouxsein
Journal:  J Bone Miner Res       Date:  2013-04       Impact factor: 6.741

Review 10.  Sclerostin: current knowledge and future perspectives.

Authors:  M J C Moester; S E Papapoulos; C W G M Löwik; R L van Bezooijen
Journal:  Calcif Tissue Int       Date:  2010-05-15       Impact factor: 4.333

View more
  43 in total

1.  Defective signaling, osteoblastogenesis and bone remodeling in a mouse model of connexin 43 C-terminal truncation.

Authors:  Megan C Moorer; Carla Hebert; Ryan E Tomlinson; Shama R Iyer; Max Chason; Joseph P Stains
Journal:  J Cell Sci       Date:  2017-01-03       Impact factor: 5.285

Review 2.  The osteocyte plays multiple roles in bone remodeling and mineral homeostasis.

Authors:  Huayue Chen; Takao Senda; Kin-ya Kubo
Journal:  Med Mol Morphol       Date:  2015-03-20       Impact factor: 2.309

Review 3.  Physiological mechanisms and therapeutic potential of bone mechanosensing.

Authors:  Zhousheng Xiao; Leigh Darryl Quarles
Journal:  Rev Endocr Metab Disord       Date:  2015-06       Impact factor: 6.514

Review 4.  Osteocyte control of bone remodeling: is sclerostin a key molecular coordinator of the balanced bone resorption-formation cycles?

Authors:  R Sapir-Koren; G Livshits
Journal:  Osteoporos Int       Date:  2014-07-17       Impact factor: 4.507

5.  Examining the influence of PTH(1-34) on tissue strength and composition.

Authors:  Joseph D Gardinier; Salam Al-Omaishi; Niloufar Rostami; Michael D Morris; David H Kohn
Journal:  Bone       Date:  2018-09-24       Impact factor: 4.398

6.  Deletion of connexin43 in osteoblasts/osteocytes leads to impaired muscle formation in mice.

Authors:  Hua Shen; Susan Grimston; Roberto Civitelli; Stavros Thomopoulos
Journal:  J Bone Miner Res       Date:  2015-04       Impact factor: 6.741

Review 7.  Joint diseases: from connexins to gap junctions.

Authors:  Henry J Donahue; Roy W Qu; Damian C Genetos
Journal:  Nat Rev Rheumatol       Date:  2017-12-19       Impact factor: 20.543

Review 8.  Shifting paradigms on the role of connexin43 in the skeletal response to mechanical load.

Authors:  Shane A Lloyd; Alayna E Loiselle; Yue Zhang; Henry J Donahue
Journal:  J Bone Miner Res       Date:  2014-02       Impact factor: 6.741

Review 9.  Connexin43 and the Intercellular Signaling Network Regulating Skeletal Remodeling.

Authors:  Megan C Moorer; Joseph P Stains
Journal:  Curr Osteoporos Rep       Date:  2017-02       Impact factor: 5.096

Review 10.  Connexins in the skeleton.

Authors:  Joseph P Stains; Roberto Civitelli
Journal:  Semin Cell Dev Biol       Date:  2015-12-29       Impact factor: 7.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.